Dr. Clay B. Siegall is a co-founder of Seattle Genetics which was formed in 1998. He chairs the Board and also the Chief Executive Officer of the company. The enterprise was established on the foundation of science and innovation, research, and the medication development practices. The company got the current leadership position by collaborating with Takeda Pharmaceuticals Company in the production of ADCETRIS which got its FDA approval in 2011 as the first product of ADC.

 

Dr. Siegall has seen to it that the Seattle Genetics received various strategic permits for the use of ADC technology. Some of the companies that collaborated are AbbVie, Genentech (Roche), and Pfizer, GlaxoSmithKline, and together have managed to make over $350 million. He has also established more than 20 ADCs who are working on the clinical development and using the technology developed by Seattle Genetics technology. Other than managing, DR. Siegal has also helped in securing over $1.2 billion by using both the public and private financing.

 

Before venturing into this company. Dr. Clay Siegall worked with the Institute of National Cancer, National Institute of wellbeing between the years 1988 up to 1991. He then went to Bristol-Myers Squibb which is a research institute dealing with pharmaceuticals from 1991-1997. He served as a board of director in Alder Biopharmaceuticals, Ultragenyx Pharmaceutical, and Washington Roundtable.

 

Dr. Siegall was driven into his career after going through a personal experience where he watched his father dealing with cancer. It was this journey that made him aware of the limitation of devices that oncologist needed. Since he wanted to improve this, he pursued Genetics and got a Ph.D. from Washington University and advanced to Zoology at the University of Maryland where he was awarded a B.S. He wanted to ensure that the tools dealing with cancer patients were improved. When he thought of starting a company, he studies on how to run a business which helped him with the venture.

 

In the course of his work, he has managed to receive many awards including the Pacific West Ernst and Young Businessperson of the year which he won in 2012 and the Alumnus of the year for Computer, Math and Natural Sciences at the University of Maryland Alumnus in 2013.